These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of the effects of chemotherapy-induced fatigue and pharmacological interventions in multiple mouse behavioral assays. Dougherty JP; Springer DA; Cullen MJ; Gershengorn MC Behav Brain Res; 2019 Mar; 360():255-261. PubMed ID: 30529403 [TBL] [Abstract][Full Text] [Related]
3. Thyrotropin-releasing hormone receptor type 1 (TRH-R1), not TRH-R2, primarily mediates taltirelin actions in the CNS of mice. Thirunarayanan N; Nir EA; Raaka BM; Gershengorn MC Neuropsychopharmacology; 2013 May; 38(6):950-6. PubMed ID: 23303050 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect and brain receptor binding of taltirelin, a novel thyrotropin-releasing hormone (TRH) analogue, in transient forebrain ischemia of C57BL/6J mice. Urayama A; Yamada S; Kimura R; Zhang J; Watanabe Y Life Sci; 2002 Dec; 72(4-5):601-7. PubMed ID: 12467901 [TBL] [Abstract][Full Text] [Related]
5. Taltirelin, a thyrotropin-releasing hormone analog, alleviates mechanical allodynia through activation of descending monoaminergic neurons in persistent inflammatory pain. Eto K; Kim SK; Nabekura J; Ishibashi H Brain Res; 2011 Sep; 1414():50-7. PubMed ID: 21872219 [TBL] [Abstract][Full Text] [Related]
6. Ibuprofen ameliorates fatigue- and depressive-like behavior in tumor-bearing mice. Norden DM; McCarthy DO; Bicer S; Devine RD; Reiser PJ; Godbout JP; Wold LE Life Sci; 2015 Dec; 143():65-70. PubMed ID: 26498217 [TBL] [Abstract][Full Text] [Related]
7. [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)]. Yamamura M; Suzuki M; Matsumoto K Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():33P-38P. PubMed ID: 9503402 [TBL] [Abstract][Full Text] [Related]
8. Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor. Thirunarayanan N; Raaka BM; Gershengorn MC Front Endocrinol (Lausanne); 2012; 3():120. PubMed ID: 23087672 [TBL] [Abstract][Full Text] [Related]
9. ShenQi FuZheng Injection ameliorates fatigue-like behavior in mouse models of cancer-related fatigue. Zhu G; Zhang B; Jiang F; Zhao L; Liu F Biomed Pharmacother; 2019 Mar; 111():1376-1382. PubMed ID: 30841452 [TBL] [Abstract][Full Text] [Related]
10. β-Arrestin2 Is Critically Involved in the Differential Regulation of Phosphosignaling Pathways by Thyrotropin-Releasing Hormone and Taltirelin. Drastichova Z; Trubacova R; Novotny J Cells; 2022 Apr; 11(9):. PubMed ID: 35563779 [TBL] [Abstract][Full Text] [Related]
11. Ganoderic acid alleviates chemotherapy-induced fatigue in mice bearing colon tumor. Abulizi A; Hu L; Ma A; Shao FY; Zhu HZ; Lin SM; Shao GY; Xu Y; Ran JH; Li J; Zhou H; Lin DM; Wang LF; Li M; Yang BX Acta Pharmacol Sin; 2021 Oct; 42(10):1703-1713. PubMed ID: 33927358 [TBL] [Abstract][Full Text] [Related]
12. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models. Kelly JA; Boyle NT; Cole N; Slator GR; Colivicchi MA; Stefanini C; Gobbo OL; Scalabrino GA; Ryan SM; Elamin M; Walsh C; Vajda A; Goggin MM; Campbell M; Mash DC; O'Mara SM; Brayden DJ; Callanan JJ; Tipton KF; Della Corte L; Hunter J; O'Boyle KM; Williams CH; Hardiman O Neuropharmacology; 2015 Feb; 89():193-203. PubMed ID: 25281210 [TBL] [Abstract][Full Text] [Related]
13. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats. Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129 [TBL] [Abstract][Full Text] [Related]
14. Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue. Norden DM; Devine R; Bicer S; Jing R; Reiser PJ; Wold LE; Godbout JP; McCarthy DO Physiol Behav; 2015 Mar; 140():230-5. PubMed ID: 25554480 [TBL] [Abstract][Full Text] [Related]
15. TRH and TRH receptor system in the basolateral amygdala mediate stress-induced depression-like behaviors. Choi J; Kim JE; Kim TK; Park JY; Lee JE; Kim H; Lee EH; Han PL Neuropharmacology; 2015 Oct; 97():346-56. PubMed ID: 26107116 [TBL] [Abstract][Full Text] [Related]
16. Thyrotropin-releasing hormone as a treatment for cancer-related fatigue: a randomized controlled study. Kamath J; Feinn R; Winokur A Support Care Cancer; 2012 Aug; 20(8):1745-53. PubMed ID: 21947558 [TBL] [Abstract][Full Text] [Related]
17. Regulation of phosphosignaling pathways involved in transcription of cell cycle target genes by TRH receptor activation in GH1 cells. Drastichova Z; Trubacova R; Novotny J Biomed Pharmacother; 2023 Dec; 168():115830. PubMed ID: 37931515 [TBL] [Abstract][Full Text] [Related]
18. Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate. Asai H; Watanabe Y; Yamauchi-Kohno R; Doi O J Recept Signal Transduct Res; 2011 Dec; 31(6):416-22. PubMed ID: 22044177 [TBL] [Abstract][Full Text] [Related]